Floatz logo

Flosteron

Radiodermatitis

Cairo UniversitySmall moleculePhase 4 / ApprovedActive
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

11 Active assets in the Radiodermatitis cohort.

Asset / SponsorPhaseRating
Olea Europaea Oil
Cairo University
Phase 4BB
Urea
University of Brasilia
Phase 3BB
Chamomilla Recutita
University of Brasilia
Phase 3BB
Mometasone
North Central Cancer Treatment Group
Phase 3BB
Cicaderma
Centre Leon Berard
Phase 3B

View all 32 →

Same molecule, other indications

Flosteron is also rated in:

psoriasisDormant
BB
Indicative · Phase 3
67 / 100
View asset →
migraine disorderDormant
BB
Indicative · Phase 4
65 / 100
View asset →
acute respiratory distress syndromeDormant
BB
Indicative · Phase 3
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →